ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026
Clinical outcomes of transvenous lead extraction in octogenarians: a real-world propensity score-matched analysis.
Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundReal-world evidence on procedural safety and clinical outcomes of transvenous lead extraction (TLE) in elderly patients remains limited. This study aimed to evaluate procedural outcomes and complications of TLE in octogenarians.
methodsPatients who underwent TLE between June 2016 and August 2025 were retrospectively analyzed. Clinical outcomes were compared between octogenarians and non-octogenarians before and after propensity score matching.
resultsOverall, 552 transvenous leads (median lead age, 8.1 years) were extracted from 380 patients (median age 67.0 years, 57.1% male). Octogenarians (n = 57, 15%) had smaller body size and a higher prevalence of comorbidities. In the propensity score-matched populations, the primary composite outcome of clinical failure and major complications did not differ significantly between non-octogenarians and octogenarians (5.3% vs. 7.0%, P = 0.908). Secondary outcomes were also comparable, including complete success (94.7% vs. 89.5%, P = 0.341) and clinical success (96.5% vs. 93.0%, P = 0.522). In multivariable analysis, octogenarian status was not associated with the primary outcome, whereas lead age (per 1 year increase) was independently associated with increased risk of the primary outcome (adjusted odds ratio, 1.12; 95% confidence interval, 1.06-1.19; P < 0.001). In subgroup analysis, female octogenarians showed a tendency toward lower procedural success and higher complication rates (complete success 97.8% vs. 82.8%, P = 0.004; clinical success 97.8% vs. 86.2%, P = 0.023; primary outcome 4.5% vs. 13.8%, P = 0.142).
conclusionsIn this real-world propensity-matched analysis, TLE in octogenarians demonstrated procedural success and safety approximating those of younger patients. A potential sex-specific vulnerability was observed in female octogenarians, which should be considered as hypothesis-generating and requires validation in further study. This study demonstrates that transvenous lead extraction can be performed safely and effectively in selected octogenarians after adjustment for procedural and lead-related confounders, with procedural success and safety approximating those of younger patients. Additionally, the observed signal of lower procedural success and higher complication rates among female octogenarians suggests a potentially vulnerable subgroup, warranting individualized risk assessment and further investigation.
Indexed as
Identifiers
42455477What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.